[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592166":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":38,"locations":45,"responsibleParty":63,"collaborators":26,"id":66,"slug":26,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":26,"eligibilityCriteria":70,"healthyVolunteers":67,"sex":71,"minAge":72,"maxAge":26,"enrollmentInfo":73,"targetDuration":26,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Navamindradhiraj University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"ESKD patient with sepsis who dialyzed with super high flux","EXPERIMENTAL","Patients received dialysis with Superhigh-flux dialyzer",[13],"Device: Super High-flux dialyzer (Elisio 19HDx)",{"label":15,"type":16,"description":17,"interventionNames":18},"ESKD with sepsis who dialyzed with high flux dialyzer","ACTIVE_COMPARATOR","Patients received dialysis with High-flux dialyzer",[19],"Device: High-flux dialyzer (Elisio 19H)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Super High-flux dialyzer (Elisio 19HDx)","Dialysis with Super High-flux dialyzer for intervention group",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"High-flux dialyzer (Elisio 19H)","Dialysis with High-flux dialyzer for control group",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Punnawit Laungchuaychok, MD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":5,"role":37},"Wanjak Pongsittisak, MD","STUDY_CHAIR",[39,43],{"name":33,"role":40,"phone":41,"phoneExt":26,"email":42},"CONTACT","022443000","punnawit@nmu.ac.th",{"name":36,"role":40,"phone":41,"phoneExt":26,"email":44},"wanjak@nmu.ac.th",[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Navamindhradhiraj university","RECRUITING","Dusit","Bangkok","11130","Thailand","TH",{"type":55,"coordinates":56},"Point",[57,58],100.51958,13.77706,{"lat":58,"lon":57},[61,62],{"name":33,"role":40,"phone":41,"phoneExt":26,"email":42},{"name":36,"role":34,"phone":26,"phoneExt":26,"email":26},{"type":34,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Punnawit Laungchuaychok","Dr.","100592166",false,"NCT06989892","Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial","Inclusion Criteria:\n\n* ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \\> 50 pg\u002Fml)\n\nExclusion Criteria:\n\n* Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.\n* Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.","ALL","18 Years",{"count":74,"type":75},202,"ESTIMATED","INTERVENTIONAL",[78],"NA","Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.",[81,82,83],"The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD","End Stage Kidney Disease (ESRD)","Sepsis",[85,86,87,88],"Superhighflux","hemodialysis","end stage kidney disease","sepsis","2025-05-19",{"date":91,"type":92},"2025-05-25","ACTUAL",{"date":94,"type":92},"2024-07-25",{"date":96,"type":75},"2026-10-01",{"name":5,"class":6},1]